Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2018-03-01
|
Series: | ACS Central Science |
Online Access: | http://dx.doi.org/10.1021/acscentsci.7b00504 |
_version_ | 1818356445241933824 |
---|---|
author | Benjamin Schumann Katrin Reppe Paulina Kaplonek Annette Wahlbrink Chakkumkal Anish Martin Witzenrath Claney L. Pereira Peter H. Seeberger |
author_facet | Benjamin Schumann Katrin Reppe Paulina Kaplonek Annette Wahlbrink Chakkumkal Anish Martin Witzenrath Claney L. Pereira Peter H. Seeberger |
author_sort | Benjamin Schumann |
collection | DOAJ |
first_indexed | 2024-12-13T19:57:19Z |
format | Article |
id | doaj.art-c646231788eb41d0a0fc2a0f3df0478c |
institution | Directory Open Access Journal |
issn | 2374-7943 2374-7951 |
language | English |
last_indexed | 2024-12-13T19:57:19Z |
publishDate | 2018-03-01 |
publisher | American Chemical Society |
record_format | Article |
series | ACS Central Science |
spelling | doaj.art-c646231788eb41d0a0fc2a0f3df0478c2022-12-21T23:33:17ZengAmerican Chemical SocietyACS Central Science2374-79432374-79512018-03-014335736110.1021/acscentsci.7b00504Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1Benjamin Schumann0Katrin Reppe1Paulina Kaplonek2Annette Wahlbrink3Chakkumkal Anish4Martin Witzenrath5Claney L. Pereira6Peter H. Seeberger7Max Planck Institute of Colloids and Interfaces, Potsdam, GermanyDivision of Pulmonary Inflammation, Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, GermanyDivision of Pulmonary Inflammation, Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, Berlin, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, GermanyMax Planck Institute of Colloids and Interfaces, Potsdam, Germanyhttp://dx.doi.org/10.1021/acscentsci.7b00504 |
spellingShingle | Benjamin Schumann Katrin Reppe Paulina Kaplonek Annette Wahlbrink Chakkumkal Anish Martin Witzenrath Claney L. Pereira Peter H. Seeberger Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1 ACS Central Science |
title | Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1 |
title_full | Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1 |
title_fullStr | Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1 |
title_full_unstemmed | Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1 |
title_short | Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1 |
title_sort | development of an efficacious semisynthetic glycoconjugate vaccine candidate against streptococcus pneumoniae serotype 1 |
url | http://dx.doi.org/10.1021/acscentsci.7b00504 |
work_keys_str_mv | AT benjaminschumann developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1 AT katrinreppe developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1 AT paulinakaplonek developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1 AT annettewahlbrink developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1 AT chakkumkalanish developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1 AT martinwitzenrath developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1 AT claneylpereira developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1 AT peterhseeberger developmentofanefficacioussemisyntheticglycoconjugatevaccinecandidateagainststreptococcuspneumoniaeserotype1 |